.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Dow
Medtronic
Cantor Fitzgerald
McKinsey
Colorcon
QuintilesIMS
Healthtrust
Harvard Business School
Teva

Generated: December 18, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 073585

« Back to Dashboard

NDA 073585 describes SUDAFED 12 HOUR, which is a drug marketed by Glaxosmithkline and Mcneil Cons and is included in two NDAs. It is available from two suppliers. Additional details are available on the SUDAFED 12 HOUR profile page.

The generic ingredient in SUDAFED 12 HOUR is pseudoephedrine hydrochloride. There are forty-nine drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the pseudoephedrine hydrochloride profile page.

Summary for 073585

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 073585

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SUDAFED 12 HOUR pseudoephedrine hydrochloride TABLET, EXTENDED RELEASE;ORAL 073585 ANDA A-S Medication Solutions 50090-1106 50090-1106-0 1 BLISTER PACK in 1 CARTON (50090-1106-0) > 10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK
SUDAFED 12 HOUR pseudoephedrine hydrochloride TABLET, EXTENDED RELEASE;ORAL 073585 ANDA Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division 50580-670 50580-670-10 1 BLISTER PACK in 1 CARTON (50580-670-10) > 10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK

Summary for product number 001

Active Rx/OTC/Discontinued:OTCDosage:TABLET, EXTENDED RELEASE;ORALStrength120MG
Approval Date:Oct 31, 1991TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chubb
Mallinckrodt
Boehringer Ingelheim
QuintilesIMS
UBS
Deloitte
McKesson
AstraZeneca
Julphar
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot